These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27067006)

  • 1. Generation of Catalytic Antibodies Is an Intrinsic Property of an Individual's Immune System: A Study on a Large Cohort of Renal Transplant Patients.
    Mahendra A; Peyron I; Thaunat O; Dollinger C; Gilardin L; Sharma M; Wootla B; Rao DN; Padiolleau-Lefevre S; Boquet D; More A; Varadarajan N; Kaveri SV; Legendre C; Lacroix-Desmazes S
    J Immunol; 2016 May; 196(10):4075-81. PubMed ID: 27067006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrolysis of coagulation factors by circulating IgG is associated with a reduced risk for chronic allograft nephropathy in renal transplanted patients.
    Wootla B; Nicoletti A; Patey N; Dimitrov JD; Legendre C; Christophe OD; Friboulet A; Kaveri SV; Lacroix-Desmazes S; Thaunat O
    J Immunol; 2008 Jun; 180(12):8455-60. PubMed ID: 18523313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IVIg treatment reduces catalytic antibody titers of renal transplanted patients.
    Mahendra A; Peyron I; Dollinger C; Gilardin L; Sharma M; Wootla B; Padiolleau-Lefevre S; Friboulet A; Boquet D; Legendre C; Kaveri SV; Thaunat O; Lacroix-Desmazes S
    PLoS One; 2013; 8(8):e70731. PubMed ID: 23967092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII.
    Lacroix-Desmazes S; Wootla B; Dasgupta S; Delignat S; Bayry J; Reinbolt J; Hoebeke J; Saenko E; Kazatchkine MD; Friboulet A; Christophe O; Nagaraja V; Kaveri SV
    J Immunol; 2006 Jul; 177(2):1355-63. PubMed ID: 16818797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of preformed IgG and IgM antibodies against donor endothelial progenitor cells in recipients of living donor kidney grafts.
    Daniel V; Sadeghi M; Suesal C; Scherer S; Tran H; Gombos P; Trojan K; Morath C; Opelz G
    Clin Transplant; 2016 Feb; 30(2):124-30. PubMed ID: 26537026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.
    Wootla B; Mahendra A; Dimitrov JD; Friboulet A; Borel-Derlon A; Rao DN; Uda T; Borg JY; Bayry J; Kaveri SV; Lacroix-Desmazes S
    FEBS Lett; 2009 Aug; 583(15):2565-72. PubMed ID: 19595998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between pretransplant serum levels of soluble CD30 and acute rejection during the first 6 months after a kidney transplant.
    Shooshtarizadeh T; Mohammadali A; Ossareh S; Ataipour Y
    Exp Clin Transplant; 2013 Jun; 11(3):229-33. PubMed ID: 23477385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
    Wieneke H; Otte B; Lang D; Heidenreich S
    Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes.
    Banasik M; Boratyńska M; Kościelska-Kasprzak K; Kamińska D; Bartoszek D; Zabińska M; Myszka M; Zmonarski S; Protasiewicz M; Nowakowska B; Hałoń A; Chudoba P; Klinger M
    Transpl Int; 2014 Oct; 27(10):1029-38. PubMed ID: 24909812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis.
    Kalaga R; Li L; O'Dell JR; Paul S
    J Immunol; 1995 Sep; 155(5):2695-702. PubMed ID: 7650397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiopathology of catalytic antibodies: the case for factor VIII-hydrolyzing immunoglobulin G.
    Wootla B; Dasgupta S; Mallet V; Kazatchkine MD; Nagaraja V; Friboulet A; Kaveri SV; Lacroix-Desmazes S
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):229-34. PubMed ID: 16651863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialylation of antibodies in kidney recipients with de novo donor specific antibody, with or without antibody mediated rejection.
    Malard-Castagnet S; Dugast E; Degauque N; Pallier A; Soulillou JP; Cesbron A; Giral M; Harb J; Brouard S
    Hum Immunol; 2016 Nov; 77(11):1076-1083. PubMed ID: 26546874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes.
    Banasik M; Boratyńska M; Kościelska-Kasprzak K; Krajewska M; Mazanowska O; Kamińska D; Bartoszek D; Zabińska M; Myszka M; Nowakowska B; Hałoń A; Dawiskiba T; Chudoba P; Klinger M
    Transpl Immunol; 2014 Jan; 30(1):24-9. PubMed ID: 24184747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring anti-HLA Class I IgG antibodies in renal transplant recipients.
    Aragão E; Moura LA; Pacheco-Silva A
    Transplant Proc; 2004 May; 36(4):836-7. PubMed ID: 15194287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of pre transplant T-cell activation status by soluble CD 30 determination.
    Abbas K; Muzaffar R; Zafar MN; Mubarak M; Naqvi SA; Rizvi SA
    J Pak Med Assoc; 2009 Apr; 59(4):212-5. PubMed ID: 19402280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
    Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presensitization accelerates chronic allograft rejection in a heterotopic rat tracheal allograft model with immunosuppression.
    Okumoto T; Yamane M; Sano Y; Aoe M; Date H; Shimizu N
    Transpl Immunol; 2007 Jun; 17(4):249-54. PubMed ID: 17493527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttransplant soluble CD30 as a predictor of acute renal allograft rejection.
    Kamali K; Abbasi MA; Farokhi B; Abbasi A; Fallah P; Seifee MH; Ghadimi N; Rezaie AR
    Exp Clin Transplant; 2009 Dec; 7(4):237-40. PubMed ID: 20353374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre- and post-transplant anti-myosin and anti-heat shock protein antibodies and cardiac transplant outcome.
    Morgun A; Shulzhenko N; Unterkircher CS; Diniz RV; Pereira AB; Silva MS; Nishida SK; Almeida DR; Carvalho AC; Franco M; Souza MM; Gerbase-DeLima M
    J Heart Lung Transplant; 2004 Feb; 23(2):204-9. PubMed ID: 14761768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leukocyte antigen G and renal allograft transplant.
    Farid E; Al-Wedaie F; Tabbara K; El-Agroudy AE; Al-Ghareeb SM
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():371-6. PubMed ID: 25894193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.